Antiepileptic Medications for the Treatment of Epilepsy

ABSTRACT

Epilepsy is one of the most common neurological conditions encountered worldwide. The development of newer antiepileptic drugs (AEDs) has expanded over recent years, and the use of such drugs for indications other than epilepsy has also broadened. These factors insure that the majority of health care providers will be using an increasing number of AEDs in the care of their patients. Contained herein is a review of the mechanism of action of AEDs, individual drugs and their potential drug interactions, and general principles to guide the clinician in selection, implementation, and long-term monitoring of AEDs.

KEYWORD

Antiepileptic drug therapy - epilepsy

REFERENCES

• 1 White H S, Woodhead J H, Wilcox K S, Stables J P, Kupferberg H J, Wolf H H. Discovery and preclinical development of antiepileptic drugs. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic Drugs 5th ed. Philadelphia: Lippincott Williams & Wilkins 2001 0: 36-48
• 2 French J A, Dichter M A. New antiepileptic drug development: medical perspective. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic Drugs 5th ed. Philadelphia: Lippincott Williams & Wilkins 2001 0: 49-57
• 3 Cramer J A, Fisher R, Menachem E B. New antiepileptic drugs: comparison of key clinical trials.  Epilepsia . 1999;  40 590-600
• 4 Cereghino J J, Mitchell W G, Murphy J. Treating repetitive seizures with a rectal diazepam formulation.  Neurology . 1998;  51 1274-1282
• 5 French J, Smith M, Faught E, Brown L. Practice advisory: the use of felbamate in the treatment of patients with intractable epilepsy.  Neurology . 1999;  52 1540-1545
• 6 US Gabapentin Study Group Number 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study.  Neurology . 1993;  43 2292-2298
• 7 Chadwick D W, Anhut H, Greiner M J. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures.  Neurology . 1998;  51 1282-1288
• 8 Matsuo F, Bergen D, Faught E. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. US Lamotrigine Protocol 0.5 Clinical Trial Group.  Neurology . 1993;  43 2284-2291
• 9 Dren A T, Moore E L, and the US Lamictal Protocol 0.5 Clinical Trial Group. Placebo-controlled, dose response evaluation of the efficacy and safety of lamotrigine as add-on therapy in epileptic outpatients with partial seizures.  Epilepsia . 1993;  32 (suppl 3) 20
• 10 Loiseau P, Yuen A WC, Douche B, Menageer T, Arne-Bes M C. A randomized double-blind placebo-controlled cross-over add-on trial of LAMICTAL in patients with treatment-resistant partial seizures.  Epilepsy Res . 1990;  7 136-145
• 11 Ramaratnam S, Marson A G, Baker G A. Lamotrigine add-on for drug-resistant partial epilepsy.  Cochrane Database Syst Rev . 2000;  (3) CD001909
• 12 Frank L M, Enlow T, Holmes G L. Lamictal (lamotrigine) monotherapy for typical absence seizures in children.  Epilepsia . 1999;  40 357-359
• 13 Steiner T J, Dellaportas C I, Findley L J. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin.  Epilepsia . 1999;  40 601-607
• 14 Motte J, Trevathan E, Arvidsson J F, Barrera M N, Mullens E L, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.  N Engl J Med . 1998;  339 851-852
• 15 Guberman A H, Besag F, Brodie M. Lamotrigine-associated rash: risk/benefit considerations in adults and children.  Epilepsia . 1999;  40 985-991
• 16 Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel AED levetiracetam (ucbL059) in the kindling model of temporal lobe epilepsy.  J Pharmacol Exp Ther . 1998;  284 474-479
• 17 Cereghino J J, Biton V, Abou-Khalil B, Dreifuss F, Gauer L J, Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.  Neurology . 2000;  55 236-242
• 18 Shorvon S D, Lowenthal A, Janz D, Bielen E, Loiseau P. Multicenter double-blind randomized, placebo controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures.  Epilepsia . 2000;  41 1179-1186
• 19 Patsalos P N. Pharmacokinetic profile of levetiracetam: toward ideal characteristics.  Pharmacol Ther . 2000;  85 77-85
• 20 Barcs G, Walker E B, Elger C E. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy.  Epilepsia . 2000;  41 1597-1607
• 21 Glauser T A, Nigro M, Sachdeo R. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.  Neurology . 2000;  54 2237-2244
• 22 Schachter S C, Vazquez B, Fisher R S. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures.  Neurology . 1999;  52 732-737
• 23 Richens A, Chadwick D W, Duncan J S. Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.  Epilepsy Res . 1995;  21 37-42
• 24 Sachdeo R C, Leroy R F, Krauss G L. Tiagabine therapy for complex partial seizures: a dose-frequency study.  Arch Neurol . 1997;  54 595-601
• 25 Uthman B M, Rowan A J, Ahmann P A. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.  Arch Neurol . 1998;  55 56-62
• 26 Biton V, Montouris G D, Ritter F. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures.  Neurology . 1999;  52 1330-1337
• 27 Abou-Khalil B. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.  Epilepsia . 2000;  41 (suppl 1) 72-76
• 28 Ritter F, Glauser  T A, Elterman R D, Wyllie E. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures.  Epilepsia . 2000;  41 (suppl 1) 82-85
• 29 Jette N J, Marson A G, Kadir Z A, Hutton J L. Topiramate for drug resistant epilepsy.  Cochrane Database Syst Rev . 2000;  (2) CD001417
• 30 Glauser T A, Levisohn P M, Ritter F, Sachdeo R C. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.  Epilepsia . 2000;  41 (suppl 1) 86-90
• 31 Chadwick D W, Marson A G. Zonisamide for drug-resistant partial epilepsy.  Cochrane Database Syst Rev . 2000;  (2) CD001416
• 32 Oommen K J, Mathews S. Zonisamide: a new antiepileptic drug.  Clin Neuropharmacol . 1999;  22 192-200
• 33 Semah F, Picot M C, Adam C. Is the underlying cause of epilepsy a major prognostic factor for recurrence?.  Neurology . 1998;  51 1256-1262
• 34 Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology.  Neurology . 1996;  47 600-602
• 35 Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepileptic drug withdrawal in patients in remission.  Lancet . 1991;  337 1175-1180
• 36 Kwan P, Brodie M J. Effectiveness of first antiepileptic drug.  Epilepsia . 2001;  42 1255-1260
• 37 Kwan P, Brodie M J. Early identification of refractory epilepsy.  N Engl J Med . 2000;  342 314-319
• 38 Dlugos D J, Sammel M D, Strom B L, Farrar J T. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy.  Neurology . 2001;  57 2259-2264
• 39 Karceski S, Morrell M, Carpenter D. The Expert Consensus Guideline Series: the treatment of epilepsy.  Epilepsy Beh . 2001;  2 A1-A50
• 40 Holmes L B, Harvey E A, Coull B A. The teratogenicity of AED drugs.  N Engl J Med . 2001;  344 1132-1138
• 41 Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology.  Neurology . 1998;  51 944-948
• 42 Zahn C A, Morrell M J, Collins S D, Labiner D M, Yerby M S. Management issues for women with epilepsy: a review of the literature. American Academy of Neurology Practice Guidelines.  Neurology . 1998;  51 949-956
• 43 Yerby M S, Annegers J F, Bruni J. A North American registry for epilepsy and pregnancy: a unique public/private partnership of health surveillance.  Epilepsia . 1998;  39 793-798